AI assistant
SoftOx Solutions AS — Share Issue/Capital Change 2021
Mar 17, 2021
3747_rns_2021-03-17_d7c5f5c3-1f72-4a1d-befd-bbeac61f3883.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
SoftOx Solutions AS: New share capital registered
SoftOx Solutions AS: New share capital registered
Reference is made to the stock exchange announcement from SoftOx Solutions AS (the "Company") on 24 February 2021 regarding the allocation and issuance of offer shares in the employee offering and to the stock exchange announcement made on 4 March 2021 regarding the final allocation of the offer shares in the subsequent offering.
The share capital increase of NOK 3,286.96 divided on 164,348 new shares in the employee offering and of NOK 3,636.36 divided on 181,818 new shares in the subsequent offering has today been registered in the Norwegian Register of Business Enterprises (Nw: Foretaksregisteret).
Following the share capital increase, the new share capital in the Company is NOK 183,369.36 divided into 9,168,468 shares, each with a nominal value of NOK 0.02.
The new shares will be listed and tradable on Euronext Growth Oslo from issuance in the Central Securities Depository (VPS).
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Kristine Rød, Finance Manager of SoftOx Solutions AS
Mail: [email protected]
Mobile: +47 977 59 071
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian MedTech company based in Oslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com